News Focus
News Focus
Post# of 257692
Next 10
Followers 843
Posts 123058
Boards Moderated 9
Alias Born 09/05/2002

Re: rfj1862 post# 221376

Friday, 10/12/2018 12:10:29 PM

Friday, October 12, 2018 12:10:29 PM

Post# of 257692
Tecentriq is recommended in first-line SCLC because of the results announced in Jun 2018 (#msg-141773668).

I highly doubt that anti-PDL1 agents generally are superior to anti-PD1 agents in this setting.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now